Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Correlation between CD14+CD16++ monocytes in peripheral blood and hypertriglyceridemia after allograft renal transplantation.

Xue D, He X, Zhou C, Xu X, Xu R, Xu N.

Transplant Proc. 2013 Nov;45(9):3279-83. doi: 10.1016/j.transproceed.2013.08.022.

PMID:
24182800
2.

CD14++ CD16+ HLA-DR+ Monocytes in Peripheral Blood are Quantitatively Correlated with the Severity of Pre-eclampsia.

Tang MX, Zhang YH, Hu L, Kwak-Kim J, Liao AH.

Am J Reprod Immunol. 2015 Aug;74(2):116-22. doi: 10.1111/aji.12389. Epub 2015 Apr 5.

PMID:
25850575
3.
4.

Elevated levels of peripheral blood CD14(bright) CD16+ and CD14(dim) CD16+ monocytes may contribute to the development of retinopathy in patients with juvenile onset type 1 diabetes.

Ryba-Stanisławowska M, Myśliwska J, Juhas U, Myśliwiec M.

APMIS. 2015 Sep;123(9):793-9. doi: 10.1111/apm.12419. Epub 2015 Jul 22.

PMID:
26200806
5.

The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.

Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY.

J Thromb Haemost. 2012 Jul;10(7):1231-41. doi: 10.1111/j.1538-7836.2011.04603.x.

6.

Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients.

Ulrich C, Heine GH, Gerhart MK, Köhler H, Girndt M.

Am J Transplant. 2008 Jan;8(1):103-10. Epub 2007 Nov 12.

7.

Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.

Amoruso A, Sola D, Rossi L, Obeng JA, Fresu LG, Sainaghi PP, Pirisi M, Brunelleschi S.

Pharmacol Res. 2016 May;107:308-14. doi: 10.1016/j.phrs.2016.03.034. Epub 2016 Apr 1.

PMID:
27045818
8.

Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.

Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, Kitabata H, Okochi K, Arita Y, Ishibashi K, Komukai K, Kataiwa H, Nakamura N, Hirata K, Tanaka A, Akasaka T.

J Am Coll Cardiol. 2009 Jul 7;54(2):130-8. doi: 10.1016/j.jacc.2009.04.021.

9.

Comparison of the proportion of non-classic (CD14+CD16+) monocytes/macrophages in peripheral blood and gingiva of healthy individuals and patients with chronic periodontitis.

Jagannathan R, Lavu V, Rao SR.

J Periodontol. 2014 Jun;85(6):852-8. doi: 10.1902/jop.2013.120658. Epub 2013 Sep 3.

PMID:
24001047
10.

CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction.

Boersema M, van den Born JC, van Ark J, Harms G, Seelen MA, van Dijk MC, van Goor H, Navis GJ, Popa ER, Hillebrands JL.

Immunobiology. 2015 May;220(5):673-83. doi: 10.1016/j.imbio.2014.11.011. Epub 2014 Nov 21.

PMID:
25476849
11.

Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients.

Okamoto H, Mizuno K, Horio T.

J Dermatol. 2003 Jul;30(7):503-9.

PMID:
12928539
12.

Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.

Chuluundorj D, Harding SA, Abernethy D, La Flamme AC.

Immunol Cell Biol. 2014 Jul;92(6):509-17. doi: 10.1038/icb.2014.15. Epub 2014 Mar 18.

PMID:
24638064
13.

Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients.

Moniuszko M, Bodzenta-Lukaszyk A, Kowal K, Lenczewska D, Dabrowska M.

Clin Immunol. 2009 Mar;130(3):338-46. doi: 10.1016/j.clim.2008.09.011. Epub 2008 Oct 25.

PMID:
18952503
14.

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation.

Sekerkova A, Krepsova E, Brabcova E, Slatinska J, Viklicky O, Lanska V, Striz I.

BMC Immunol. 2014 Feb 6;15:4. doi: 10.1186/1471-2172-15-4.

15.

Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.

Czepluch FS, Kuschicke H, Dellas C, Riggert J, Hasenfuss G, Schäfer K.

J Intern Med. 2014 Feb;275(2):144-54. doi: 10.1111/joim.12145. Epub 2013 Oct 30.

16.

Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.

Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, Sugasawa H, Kinoshita M, Hiraide H, Mochizuki H.

J Endotoxin Res. 2004;10(4):229-37.

PMID:
15373966
17.

Expression of CD14, CD16 and CD45RA on monocytes from periodontitis patients.

Nagasawa T, Kobayashi H, Aramaki M, Kiji M, Oda S, Izumi Y.

J Periodontal Res. 2004 Feb;39(1):72-8.

PMID:
14687231
18.

Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever.

Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes-Carvalho A, Zagne SM, Nogueira RM, Oliveira-Pinto LM, Kubelka CF.

Immunology. 2010 Jun;130(2):202-16. doi: 10.1111/j.1365-2567.2009.03224.x. Epub 2010 Jan 27.

19.

Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.

Skrzeczyńska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J.

Scand J Immunol. 2008 Feb;67(2):152-9. doi: 10.1111/j.1365-3083.2007.02051.x.

20.

CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.

Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, Iwahashi M, Ueno A, Ohmoto Y, Makino H.

Arthritis Rheum. 2002 Oct;46(10):2578-86.

Supplemental Content

Support Center